Advanced search
Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 31, 2017 - Issue 12
Submit an article Journal homepage
250
Views
7
CrossRef citations to date
0
Altmetric
Short Communication

Acetone and methanol fruit extracts of Terminalia paniculata inhibit HIV-1 infection in vitro

Ankita DurgeDepartment of Virology, National AIDS Research Institute, Pune, India
,
Pratiksha JadaunDepartment of Virology, National AIDS Research Institute, Pune, India
,
Ashish WadhwaniDepartment of Virology, National AIDS Research Institute, Pune, India
,
Ashish A. ChinchansureDivision of Organic Chemistry, CSIR-National Chemical Laboratory, Pune, India
,
Madhukar SaidDivision of Organic Chemistry, CSIR-National Chemical Laboratory, Pune, India
,
H. V. ThulasiramDivision of Organic Chemistry, CSIR-National Chemical Laboratory, Pune, India
,
Swati P. JoshiDivision of Organic Chemistry, CSIR-National Chemical Laboratory, Pune, India
&
Smita S. KulkarniDepartment of Virology, National AIDS Research Institute, Pune, IndiaCorrespondence[email protected]
 show all
Pages 1468-1471 | Received 06 Sep 2016, Accepted 19 Oct 2016, Published online: 20 Nov 2016

References

  • Ahn MJ, Kim CY, Lee JS, Kim TG, Kim SH, Lee CK, Lee BB, Shin CG, Huh H, Kim J. 2002. Inhibition of HIV-1 integrase by galloyl glucoses from Terminalia chebula and flavonol glycoside gallates from Euphorbia pekinensis. Planta Med. 68:457–459.10.1055/s-2002-32070
  • Ambika SPP, Chauhan SMS. 2014. Activity-guided isolation of antioxidants from the leaves of Terminalia arjuna. Nat Prod Res. 28:760–763.
  • Bag A, Chattopadhyay RR. 2014. Efflux-pump inhibitory activity of a gallotannin from Terminalia chebula fruit against multidrug-resistant uropathogenic Escherichia coli. Nat Prod Res. 28:1280–1283.10.1080/14786419.2014.895729
  • Beutler JA. 2009. Natural products as a foundation for drug discovery. Curr protoc pharmacol / editorial board, SJ Enna. 46:9.11.1–9.11.21.
  • CDC. 1981. Pneumocystis pneumonia – Los Angeles. MMWR. 30:250–252.
  • Harvey A. 2000. Strategies for discovering drugs from previously unexplored natural products. Drug Discovery Today. 5:294–300.10.1016/S1359-6446(00)01511-7
  • Johnston R, Barré-Sinoussi F. 2012. Controversies in HIV cure research. J Int AIDS Soc. 15:16–23.10.1186/1758-2652-15-16
  • Joshi SP, Kulkarni SS. 2013. Microbiocides from plant extract for protection against HSV 2 infection. U.S. patent Application No 14/398,313.
  • Martino VS, López P, Martinez-Irujo JJ, Sanromán M, Cuevas MT, Santiago E, Lasarte JJ, Font M, Coussio JD, Monge A. 2002. Inhibitory effect against polymerase and ribonuclease activities of HIV-reverse transcriptase of the aqueous leaf extract of Terminalia triflora. Phytother Res. 16:778–780.10.1002/ptr.1065
  • Martino V, Morales J, Martínez-Irujo JJ, Font M, Monge A, Coussio J. 2004. Two ellagitannins from the leaves of Terminalia triflora with inhibitory activity on HIV-1 reverse transcriptase. Phytother Res. 18:667–669.10.1002/ptr.1504
  • Nadkarni A. K. 1996. Terminalia paniculata Roxb. In: Nadkarni AK, Nadkarni KM, editors. Indian materia medica. 3rd ed. Mumbai: Popular Prakashan; p.1121.
  • Newman DJ, Cragg GM. 2012. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod. 75:311–335.10.1021/np200906s
  • Seal A, Aykkal R, Babu RO, Ghosh M. 2011. Docking study of HIV-1 reverse transcriptase with phytochemicals. Bioinformation. 5:430–439.10.6026/bioinformation
  • Stadeli KM, Richman DD. 2013. Rates of emergence of HIV drug resistance in resource-limited settings: a systematic review. Antiviral Ther. 18:115–123.
  • Talwar S, Nandakumar K, Nayak PG, Bansal P, Mudgal J, Mor V, Rao CM, Lobo R. 2011. Anti-inflammatory activity of Terminalia paniculata bark extract against acute and chronic inflammation in rats. J Ethnopharmacol. 134:323–328.10.1016/j.jep.2010.12.015
  • Tshikalange TE, Meyer JJM, Lall N, Muñoz E, Sancho R, Van de Venter M, Oosthuizen V. 2008. In vitro anti-HIV-1 properties of ethnobotanically selected South African plants used in the treatment of sexually transmitted diseases. J Ethnopharmacol. 119:478–481.10.1016/j.jep.2008.08.027
  • Valsaraj R, Pushpangadan P, Smitt UW, Adsersen A, Christensen SB, Sittie A, Nyman U, Nielsen C, Olsen CE. 1997. New anti-HIV-1, antimalarial, and antifungal compounds from Terminalia bellerica. J Nat Prod. 60:739–742.10.1021/np970010m
  • Yu YB, Miyashiro H, Nakamura N, Hattori M, Park JC. 2007. Effects of triterpenoids and flavonoids isolated from Alnus firma on HIV-1 viral enzymes. Arch Pharmacal Res. 30:820–826.10.1007/BF02978831

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.